ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM

Xinmiao Long,Zuping Zhang,Yuzhe Li,Kun Deng,Wei Gao,Meng Huang,Xiangyu Wang,Xiang Lin,Xiaoling She,Yiming Zhao,Minfu Zhang,Cheng Huang,Shiyi Wang,Yinfei Du,Peng Du,Shuai Chen,Qing Liu,Minghua Wu

DOI: https://doi.org/10.1136/jitc-2024-008967

IF: 12.469

2024-04-01

Journal for ImmunoTherapy of Cancer

Abstract:Background Glioblastoma (GBM) is a fatal primary brain malignancy in adults. Previous studies have shown that cytomegalovirus (CMV) is a risk factor for tumorigenesis and aggressiveness for glioblastoma. However, little is known about how CMV infection affects immune cells in the tumor microenvironment of GBM. Furthermore, there has been almost no engineered T-cell receptor (TCR)-T targeting CMV for GBM research to date. Methods We evaluated the CMV infection status of patients with GBM’s tumor tissue by immune electron microscopy, immunofluorescence, and droplet digital PCR. We performed single-cell RNA sequencing for CMV-infected GBM to investigate the effects of CMV on the GBM immune microenvironment. CellChat was applied to analyze the interaction between cells in the GBM tumor microenvironment. Additionally, we conducted single-cell TCR/B cell receptor (BCR) sequencing and Grouping of Lymphocyte Interactions with Paratope Hotspots 2 algorithms to acquire specific CMV-TCR sequences. Genetic engineering was used to introduce CMV-TCR into primary T cells derived from patients with CMV-infected GBM. Flow cytometry was used to measure the proportion and cytotoxicity status of T cells in vitro. Results We identified two novel immune cell subpopulations in CMV-infected GBM, which were bipositive CD68 + SOX2 + tumor-associated macrophages and FXYD6 + T cells. We highlighted that the interaction between bipositive TAMs or cancer cells and T cells was predominantly focused on FXYD6 + T cells rather than regulatory T cells (Tregs), whereas, FXYD6 + T cells were further identified as a group of novel immunosuppressive T cells. CMV-TCR-T cells showed significant therapeutic effects on the human-derived orthotopic GBM mice model. Conclusions These findings provided an insight into the underlying mechanism of CMV infection promoting the GBM immunosuppression, and provided a novel potential immunotherapy strategy for patients with GBM.

oncology,immunology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how cytomegalovirus (CMV) infection affects the immune microenvironment of glioblastoma (GBM), especially the impact of CMV infection on tumor - associated macrophages (TAMs) and T cells. In addition, the study also aims to develop T - cell therapies targeting CMV - specific T - cell receptors (TCR) to evaluate their therapeutic effects on GBM.

Specifically, the paper mainly focuses on the following points:
1. **The impact of CMV infection on the GBM immune microenvironment**: Through single - cell RNA sequencing (scRNA - seq) technology, the researchers found that CMV infection promotes the expansion of double - positive CD68+SOX2+ TAMs, and there is an interaction between these TAMs and newly identified immunosuppressive FXYD6+ T cells, leading to T - cell exhaustion and exacerbating the immunosuppressive microenvironment of GBM.
2. **The development of CMV - TCR - T cells and their therapeutic effects**: The researchers introduced CMV - TCR into primary T cells from CMV - infected GBM patients through genetic engineering and found that these CMV - TCR - T cells showed significant anti - tumor effects in both in vitro and in vivo experiments.

Through these studies, the paper provides new insights into the mechanism of CMV infection in GBM and potential strategies for developing new immunotherapy methods for GBM.